Alzheimer Disease Vaccine
Adenovirus vector induced an anti-inflammatory immune response
Published in Vaccine Weekly, November 23rd, 2005
"Induction of an immune response to amyloid-beta protein (A-beta) is effective in treating animal models of Alzheimer disease. Human clinical trials of vaccination with synthetic A-beta (ANI 792), however, were halted due to brain inflammation, presumably induced by T cell-mediated immune responses. We have developed an adenovirus vector as a 'possibly safer' vaccine. Here, we show that an adenovirus vector encoding 11 tandem repeats of A-beta 1-6 can induce an immune response against amyloid beta-protein," researchers in the United States report.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2005-11-23)
More Articles from Vaccine Weekly
- Anthrax Vaccine Development
Nonhuman primate adenovirus-based vaccine protected against anthrax toxin - Coccidioidomycosis Vaccine
Dendritic cell vaccine protects mice against Coccidioides posadasii - Malaria Vaccine
Three Plasmodium proteins show promise as combination vaccine - Rotavirus Vaccine
Attenuated rotavirus vaccine protects against rotavirus infection - Alzheimer Disease Vaccine
Aldolase is target antigen in Alzheimer disease - Antimicrobials
LaeA regulates morphogenetic fungal virulence factors - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
